ClinVar Miner

Submissions for variant NM_002471.4(MYH6):c.2591C>T (p.Thr864Met)

gnomAD frequency: 0.00008  dbSNP: rs200153625
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000172564 SCV000050991 likely benign not provided 2013-06-24 criteria provided, single submitter research
Blueprint Genetics RCV000208173 SCV000264069 uncertain significance Primary familial hypertrophic cardiomyopathy 2015-03-26 criteria provided, single submitter clinical testing
Invitae RCV000821750 SCV000962519 uncertain significance Hypertrophic cardiomyopathy 14 2023-12-17 criteria provided, single submitter clinical testing This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 864 of the MYH6 protein (p.Thr864Met). This variant is present in population databases (rs200153625, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MYH6-related conditions. ClinVar contains an entry for this variant (Variation ID: 192122). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYH6 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV000172564 SCV002526487 uncertain significance not provided 2022-06-09 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 23861362)
Ambry Genetics RCV002433759 SCV002745411 uncertain significance Cardiovascular phenotype 2022-11-15 criteria provided, single submitter clinical testing The p.T864M variant (also known as c.2591C>T), located in coding exon 19 of the MYH6 gene, results from a C to T substitution at nucleotide position 2591. The threonine at codon 864 is replaced by methionine, an amino acid with similar properties. This variant has been detected in a case with hypoplastic left heart syndrome (Theis JL et al. Circ Genom Precis Med. 2021 02;14(1):e003126). This variant has also been reported as a secondary cardiac variant in an exome cohort (Ng D et al. Circ Cardiovasc Genet, 2013 Aug;6:337-46). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Dept of Medical Biology, Uskudar University RCV003318361 SCV004021989 uncertain significance Long QT syndrome 2024-01-08 criteria provided, single submitter research Criteria: Not met
CeGaT Center for Human Genetics Tuebingen RCV000172564 SCV005093361 likely benign not provided 2024-07-01 criteria provided, single submitter clinical testing MYH6: BP4, BS2

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.